bioRxiv Science⌕ Search

bioRxiv · 10.1101/2021.07.16.452528

A flexible Bayesian approach to estimating size-structured matrix population models

Abstract

The rates of cell growth, division, and carbon loss of microbial populations are key parameters for understanding how organisms interact with their environment and how they contribute to the carbon cycle. However, the invasive nature of current analytical methods has hindered efforts to reliably quantify these parameters. In recent years, size-structured matrix population models (MPMs) have gained popularity for estimating rate parameters of microbial populations by mechanistically describing changes in microbial cell size distributions over time. And yet, the construction, analysis, and biological interpretation of these models are underdeveloped, as current implementations do not adequately constrain or assess the biological feasibility of parameter values, leading to inference which may provide a good fit to observed size distributions but does not necessarily reflect realistic physiological dynamics. Here we present a flexible Bayesian extension of size-structured MPMs for testing underlying assumptions describing the dynamics of a marine phytoplankton population over the day-night cycle. Our Bayesian framework takes prior scientific knowledge into account and generates biologically interpretable results. Using data from an exponentially growing laboratory culture of the cyanobacterium Prochlorococcus, we herein demonstrate the performance improvements of our approach over current models and isolate previously ignored biological processes, such as respiratory and exudative carbon losses, as critical parameters for the modeling of microbial population dynamics. The results demonstrate that this modeling framework can provide deeper insights into microbial population dynamics provided by flow-cytometry time-series data. Author summaryIdentifying the growth and population dynamics of marine microorganisms in their natural habitat is crucial to understanding the flow of carbon in the oceans but remains a grand challenge due to the invasive nature of current measurement methods. As time-series observations of population size structure have become more commonplace in aquatic environments, matrix population models (MPMs), which aim to mechanistically describe the change in size structure of these populations over time, have gained in popularity over the last decade. However, the underlying assumptions and behavior of MPMs have not been adequately scrutinized, and parameter values are difficult to interpret biologically, leading to inference that may not reflect plausible physiological dynamics. Here, we develop a Bayesian extension of the MPM framework to examine biological assumptions, improve interpretability of model output, and account for additional biological processes. We evaluated the performance of our models on a publicly available dataset of laboratory experiment time-series measurements of the cyanobacterium Prochlorococcus, Earths most abundant photosynthetic organisms, demonstrated the performance improvements of our approach over current models, and isolated previously ignored respiratory and exudative carbon losses as critical parameters for the modeling of microbial population dynamics.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Mattern, J. P., Glauninger, K., Britten, G. L., Casey, J., Hyun, S., Wu, Z., Armbrust, E. V., Harchaoui, Z., Ribalet, F.. 2021-07-16. A flexible Bayesian approach to estimating size-structured matrix population models. https://doi.org/10.1101/2021.07.16.452528

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology↗

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology↗

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology↗